Your browser is no longer supported. Please, upgrade your browser.
Settings
ABMD Abiomed, Inc. daily Stock Chart
ABMD [NASD]
Abiomed, Inc.
IndexS&P 500 P/E53.76 EPS (ttm)4.43 Insider Own1.40% Shs Outstand45.04M Perf Week14.57%
Market Cap10.72B Forward P/E49.25 EPS next Y4.83 Insider Trans-2.47% Shs Float44.08M Perf Month31.51%
Income203.00M PEG2.24 EPS next Q0.29 Inst Own98.40% Short Float6.52% Perf Quarter54.34%
Sales840.90M P/S12.75 EPS this Y-21.00% Inst Trans-3.00% Short Ratio4.33 Perf Half Y23.84%
Book/sh23.66 P/B10.06 EPS next Y42.90% ROA17.40% Target Price204.40 Perf Year-10.87%
Cash/sh9.84 P/C24.20 EPS next 5Y24.00% ROE19.80% 52W Range119.01 - 285.77 Perf YTD39.54%
Dividend- P/FCF39.58 EPS past 5Y10.80% ROI17.90% 52W High-16.70% Beta0.89
Dividend %- Quick Ratio4.10 Sales past 5Y29.60% Gross Margin82.00% 52W Low100.02% ATR8.73
Employees1536 Current Ratio4.80 Sales Q/Q-0.20% Oper. Margin29.10% RSI (14)85.45 Volatility4.41% 3.88%
OptionableYes Debt/Eq0.00 EPS Q/Q-56.30% Profit Margin24.10% Rel Volume1.10 Prev Close230.66
ShortableYes LT Debt/Eq0.00 EarningsApr 30 BMO Payout0.00% Avg Volume664.72K Price238.04
Recom2.30 SMA2019.47% SMA5036.21% SMA20033.23% Volume729,106 Change3.20%
Apr-27-20Downgrade SVB Leerink Outperform → Mkt Perform $175
Feb-12-20Downgrade Morgan Stanley Equal-Weight → Underweight $165
Feb-06-20Resumed BTIG Research Neutral
Oct-29-19Downgrade Raymond James Outperform → Mkt Perform
Aug-02-19Downgrade Morgan Stanley Overweight → Equal-Weight $325 → $215
Aug-02-19Downgrade Guggenheim Buy → Neutral
Aug-01-19Downgrade BTIG Research Buy → Neutral
Nov-07-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-02-18Upgrade BTIG Research Neutral → Buy
Jun-22-18Reiterated Piper Jaffray Overweight $360 → $480
Apr-04-18Initiated Goldman Buy $332
Jan-19-18Reiterated Leerink Partners Outperform $200 → $265
Oct-16-17Downgrade BTIG Research Buy → Neutral
Sep-29-17Initiated SunTrust Buy $195
Jun-08-17Resumed William Blair Outperform
Apr-06-17Upgrade Piper Jaffray Neutral → Overweight
Dec-07-16Initiated Guggenheim Buy
Oct-30-15Upgrade Raymond James Mkt Perform → Outperform
Aug-18-15Initiated Sterne Agee CRT Buy $130
Aug-12-15Reiterated The Benchmark Company Buy $96 → $129
Jun-03-20 09:35AM  
Jun-01-20 02:05PM  
12:06PM  
08:03AM  
07:42AM  
07:00AM  
May-30-20 11:31AM  
May-27-20 04:30PM  
11:40AM  
May-20-20 07:00AM  
May-19-20 09:32AM  
May-18-20 01:25PM  
May-15-20 10:38AM  
May-11-20 02:39PM  
02:32PM  
May-07-20 10:00AM  
May-05-20 10:09AM  
May-03-20 08:06AM  
May-01-20 06:25AM  
Apr-30-20 03:44PM  
02:30PM  
02:06PM  
10:30AM  
08:35AM  
Apr-29-20 07:29PM  
11:09AM  
Apr-24-20 09:59AM  
Apr-23-20 12:32PM  
Apr-10-20 07:00AM  
Apr-08-20 06:21AM  
Mar-26-20 11:40AM  
Mar-25-20 07:05AM  
Mar-22-20 11:05PM  
Mar-19-20 07:11PM  
Mar-10-20 11:40AM  
Mar-09-20 10:13AM  
07:23AM  
Mar-07-20 11:30AM  
Mar-04-20 07:05AM  
Feb-24-20 08:52AM  
Feb-12-20 02:35AM  
Feb-10-20 11:47AM  
05:30AM  
Feb-07-20 04:01PM  
Feb-06-20 09:30AM  
07:00AM  
06:00AM  
Feb-05-20 08:52AM  
Jan-31-20 10:44AM  
Jan-30-20 02:57PM  
Jan-27-20 03:16PM  
Jan-25-20 08:02AM  
Jan-21-20 04:18PM  
Jan-18-20 12:46PM  
Jan-14-20 07:22AM  
Jan-13-20 12:50PM  
10:17AM  
07:00AM  
06:29AM  
Jan-03-20 12:10PM  
Jan-02-20 01:05PM  
Dec-30-19 08:24AM  
07:00AM  
05:12AM  
Dec-28-19 04:22PM  
Dec-24-19 01:14PM  
Dec-21-19 04:51PM  
Dec-20-19 04:29PM  
Dec-19-19 06:50PM  
Dec-18-19 12:56PM  
Dec-16-19 03:02PM  
12:25PM  
08:05AM  
07:58AM  
Dec-12-19 07:06AM  
Dec-11-19 04:03PM  
Dec-04-19 09:11AM  
05:00AM  
Dec-03-19 04:45PM  
11:22AM  
05:18AM  
Nov-29-19 06:26PM  
Nov-28-19 07:00AM  
Nov-27-19 03:08PM  
07:00AM  
Nov-19-19 01:11PM  
Nov-18-19 01:51PM  
07:01AM  
Nov-14-19 09:59AM  
Nov-12-19 07:05AM  
Nov-11-19 06:40PM  
Nov-08-19 02:18PM  
Nov-05-19 06:20AM  
Oct-31-19 06:58PM  
02:25PM  
10:02AM  
09:01AM  
08:15AM  
07:02AM  
07:00AM  
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company engages in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUTTER MARTIN PDirectorMay 04Option Exercise9.9912,000119,880200,939May 06 04:02 PM
SUTTER MARTIN PDirectorMay 04Sale180.5812,0002,166,928188,939May 06 04:02 PM
THOMAS PAULDirectorMar 02Sale151.782,000303,5618,920Mar 04 04:23 PM
THOMAS PAULDirectorFeb 10Sale181.132,000362,25010,920Feb 12 05:14 PM
Weber David MChief Operating OfficerAug 05Option Exercise21.554,17589,971132,913Aug 07 04:15 PM
Weber David MChief Operating OfficerAug 05Sale206.268,0951,669,693124,818Aug 07 04:15 PM